Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
2(66.7%)
Phase 2
1(33.3%)
3Total
Phase 4(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03844360Phase 4Recruiting

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Role: lead

NCT05459597Recruiting

Antiepileptic Drugs in Elderly Patients

Role: lead

NCT04228393Phase 2Unknown

The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China

Role: lead

NCT03960905Unknown

A Study the Population Pharmacokinetics of Children of Infectious Disease in Central Nervous System

Role: lead

NCT03960671Phase 4Unknown

Therapeutic Drug Monitoring of Anxiolytics in Children

Role: lead

All 5 trials loaded